相关实验视频
Updated: Jun 29, 2025
04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
256
全球对双相情感障碍治疗的观点:对选择药物的国际指导方针进行深入的比较分析
Ji Hyun Park1, Kaveesha Fernando1, Youngja Hwang Park2
1College of Pharmacy, Duksung Women's University, Seoul, Republic of Korea.
BJPsych open
|April 8, 2024
概括
双极性障碍治疗指南在全球范围内因不同的研究解释和国家政策而有所不同. 需要更多的大规模研究,以提供一致的,基于证据的双相情感障碍管理建议.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性障碍是一种慢性精神健康状况,影响全球数百万人,需要全面的管理策略.
- 治疗指南对于临床医生来说至关重要,以控制症状,预防复发,并改善双相情感障碍患者的福祉.
- 在不同国家的双相情感障碍治疗指南中存在显著的差异.
研究的目的:
- 探索和比较双相情感障碍的国际治疗指南.
- 确定影响治疗方法的因素和双相情感障碍管理的变化.
- 为完善双相情感障碍治疗中的基于证据的实践提供见解.
主要方法:
- 对国际双相情感障碍治疗指南的分析,在2014年之后更新.
- 审查来自英国,加拿大,澳大利亚/新西兰,韩国和国际神经心理药理学院的指导方针.
- 确定导致指导方针建议差异的因素.
主要成果:
- 准则的变化源于开发方法 (专家共识与元分析),分析时间和研究选择.
- 代谢酶和国家卫生政策的种族差异也导致了治疗变化.
- 对双相情感障碍的推药理干预措施的差异在不同地区是明显的.
结论:
- 缺乏高质量的研究是导致双相情感障碍治疗结论一致的主要障碍.
- 指导方针的变化凸显了需要更强大,更大规模的研究.
- 加强基于证据的建议需要专门的研究来评估双相情感障碍的治疗方法.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
176
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176
01:30Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:26Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
55
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
55